Subcellular localization of a fluorescent derivative of CuII(atsm) offers insight into the neuroprotective action of CuII(atsm)
Open Access
- 1 January 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Metallomics
- Vol. 3 (12) , 1280-1290
Abstract
Copper complexes of bis(thiosemicarbazone) (CuII(btsc)s) have been studied as potential anti-cancer agents and hypoxia imaging agents. More recently,Keywords
This publication has 25 references indexed in Scilit:
- Copper complexes of bis(thiosemicarbazones): from chemotherapeutics to diagnostic and therapeutic radiopharmaceuticalsChemical Society Reviews, 2011
- Metal Ionophore Treatment Restores Dendritic Spine Density and Synaptic Protein Levels in a Mouse Model of Alzheimer's DiseasePLOS ONE, 2011
- The role of coordination chemistry in the development of copper and rhenium radiopharmaceuticalsDalton Transactions, 2011
- Increasing Cu bioavailability inhibits Aβ oligomers and tau phosphorylationProceedings of the National Academy of Sciences, 2009
- Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial AβNeuron, 2008
- Selective Intracellular Release of Copper and Zinc Ions from Bis(thiosemicarbazonato) Complexes Reduces Levels of Alzheimer Disease Amyloid-β PeptideJournal of Biological Chemistry, 2008
- Assessing Tumor Hypoxia in Cervical Cancer by PET with 60Cu-Labeled Diacetyl-Bis(N4-Methylthiosemicarbazone)Journal of Nuclear Medicine, 2008
- Degradation of the Alzheimer Disease Amyloid β-Peptide by Metal-dependent Up-regulation of Metalloprotease ActivityJournal of Biological Chemistry, 2006
- Fluorescence studies of the intra-cellular distribution of zinc bis(thiosemicarbazone) complexes in human cancer cellsChemical Communications, 2005
- Redox-active metal complexes for imaging hypoxic tissues: structure–activity relationships in copper(ii) bis(thiosemicarbazone) complexesChemical Communications, 1998